Novartis Institutes for Biomedical Research (NIBR) uses high-performance computing (HPC) to accelerate drug discovery through phenotypic assays, deep learning for image analysis, and pushing analysis tools to scientists. NIBR's HPC resources include x86 servers, specialized nodes with GPUs and large memory, and software for modeling, simulation, and analysis. Examples shown how HPC has increased throughput for monitoring neuron and muscle cell interaction, classified images better than conventional methods, and allowed scientists to directly run analyses on cluster resources.